Sparing Organs at Risk with Simultaneous Integrated Boost Volumetric Modulated Arc Therapy for Locally Advanced Non-Small Cell Lung Cancer: An Automatic Treatment Planning Study.
Daquan WangJiayun ChenXiaodong ZhangTao ZhangLuhua WangQinfu FengZongmei ZhouJianrong DaiNan BiPublished in: Cancer management and research (2020)
SIB-VMAT technique could lead to a substantial sparing of normal organs, including lung, heart, esophagus and cord, mainly through reducing high and inter-median dose exposure. Patients with CTV/(GTV+GTVnd) ≥8.6 might benefit more from SIB-VMAT.